Annual EBITDA
$5.12 M
+$44.63 M+112.96%
31 December 2023
Summary:
ADMA Biologics annual earnings before interest, taxes, depreciation & amortization is currently $5.12 million, with the most recent change of +$44.63 million (+112.96%) on 31 December 2023. During the last 3 years, it has risen by +$64.94 million (+108.56%). ADMA annual EBITDA is now at all-time high.ADMA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$42.19 M
+$507.00 K+1.22%
30 September 2024
Summary:
ADMA Biologics quarterly earnings before interest, taxes, depreciation & amortization is currently $42.19 million, with the most recent change of +$507.00 thousand (+1.22%) on 30 September 2024. Over the past year, it has increased by +$31.13 million (+281.62%). ADMA quarterly EBITDA is now at all-time high.ADMA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$98.83 M
+$31.13 M+45.99%
30 September 2024
Summary:
ADMA Biologics TTM earnings before interest, taxes, depreciation & amortization is currently $98.83 million, with the most recent change of +$31.13 million (+45.99%) on 30 September 2024. Over the past year, it has increased by +$88.95 million (+900.18%). ADMA TTM EBITDA is now at all-time high.ADMA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +113.0% | +281.6% | +900.2% |
| 3 y3 years | +108.6% | +424.7% | +275.4% |
| 5 y5 years | +109.0% | +629.3% | +321.1% |
ADMA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +108.6% | at high | +310.6% | at high | +267.0% |
| 5 y | 5 years | at high | +108.6% | at high | +310.6% | at high | +265.2% |
| alltime | all time | at high | +108.6% | at high | +310.6% | at high | +265.2% |
ADMA Biologics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $42.19 M(+1.2%) | $98.83 M(+46.0%) |
| June 2024 | - | $41.68 M(+71.6%) | $67.70 M(+141.4%) |
| Mar 2024 | - | $24.28 M(-360.5%) | $28.04 M(+447.8%) |
| Dec 2023 | $5.12 M(-113.0%) | -$9.32 M(-184.3%) | $5.12 M(-48.2%) |
| Sept 2023 | - | $11.05 M(+445.7%) | $9.88 M(-214.5%) |
| June 2023 | - | $2.03 M(+49.1%) | -$8.63 M(-52.4%) |
| Mar 2023 | - | $1.36 M(-129.8%) | -$18.12 M(-54.1%) |
| Dec 2022 | -$39.51 M(-25.6%) | -$4.56 M(-38.9%) | -$39.51 M(-15.5%) |
| Sept 2022 | - | -$7.46 M(-0.1%) | -$46.77 M(-10.6%) |
| June 2022 | - | -$7.47 M(-62.7%) | -$52.30 M(-11.6%) |
| Mar 2022 | - | -$20.03 M(+69.5%) | -$59.17 M(+11.4%) |
| Dec 2021 | -$53.09 M(-11.2%) | -$11.82 M(-9.1%) | -$53.09 M(-5.8%) |
| Sept 2021 | - | -$12.99 M(-9.4%) | -$56.35 M(+0.4%) |
| June 2021 | - | -$14.33 M(+2.7%) | -$56.14 M(-3.3%) |
| Mar 2021 | - | -$13.95 M(-7.4%) | -$58.04 M(-3.0%) |
| Dec 2020 | -$59.82 M(+66.0%) | -$15.07 M(+17.8%) | -$59.82 M(+15.6%) |
| Sept 2020 | - | -$12.79 M(-21.2%) | -$51.76 M(+10.3%) |
| June 2020 | - | -$16.23 M(+3.1%) | -$46.94 M(+14.4%) |
| Mar 2020 | - | -$15.74 M(+124.8%) | -$41.04 M(+13.9%) |
| Dec 2019 | -$36.03 M(-36.5%) | -$7.00 M(-12.2%) | -$36.03 M(-19.4%) |
| Sept 2019 | - | -$7.97 M(-22.9%) | -$44.70 M(-9.9%) |
| June 2019 | - | -$10.33 M(-3.6%) | -$49.62 M(-4.3%) |
| Mar 2019 | - | -$10.72 M(-31.6%) | -$51.83 M(-8.7%) |
| Dec 2018 | -$56.77 M(+50.3%) | -$15.68 M(+21.7%) | -$56.77 M(+10.5%) |
| Sept 2018 | - | -$12.89 M(+2.7%) | -$51.38 M(-1.3%) |
| June 2018 | - | -$12.54 M(-20.0%) | -$52.08 M(+9.3%) |
| Mar 2018 | - | -$15.67 M(+52.4%) | -$47.65 M(+26.1%) |
| Dec 2017 | -$37.78 M | -$10.28 M(-24.3%) | -$37.78 M(+20.7%) |
| Sept 2017 | - | -$13.58 M(+67.4%) | -$31.31 M(+46.7%) |
| June 2017 | - | -$8.12 M(+39.9%) | -$21.34 M(+14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$5.80 M(+52.1%) | -$18.58 M(+10.6%) |
| Dec 2016 | -$16.81 M(+7.3%) | -$3.81 M(+5.7%) | -$16.81 M(-1.1%) |
| Sept 2016 | - | -$3.61 M(-32.7%) | -$16.99 M(-5.2%) |
| June 2016 | - | -$5.36 M(+33.1%) | -$17.92 M(+7.5%) |
| Mar 2016 | - | -$4.03 M(+0.6%) | -$16.67 M(+6.5%) |
| Dec 2015 | -$15.66 M(-1.1%) | -$4.00 M(-11.8%) | -$15.66 M(+2.4%) |
| Sept 2015 | - | -$4.54 M(+10.4%) | -$15.29 M(+11.2%) |
| June 2015 | - | -$4.11 M(+36.4%) | -$13.75 M(+4.1%) |
| Mar 2015 | - | -$3.01 M(-17.2%) | -$13.21 M(-16.5%) |
| Dec 2014 | -$15.83 M(+7.7%) | -$3.64 M(+21.4%) | -$15.83 M(-5.1%) |
| Sept 2014 | - | -$3.00 M(-16.1%) | -$16.68 M(+3.2%) |
| June 2014 | - | -$3.57 M(-36.6%) | -$16.15 M(-6.4%) |
| Mar 2014 | - | -$5.63 M(+25.6%) | -$17.26 M(+17.4%) |
| Dec 2013 | -$14.70 M(+90.7%) | -$4.48 M(+81.4%) | -$14.70 M(+7.1%) |
| Sept 2013 | - | -$2.47 M(-47.2%) | -$13.72 M(-1.7%) |
| June 2013 | - | -$4.68 M(+52.4%) | -$13.96 M(+33.7%) |
| Mar 2013 | - | -$3.07 M(-12.5%) | -$10.44 M(+22.4%) |
| Dec 2012 | -$7.71 M(>+9900.0%) | -$3.51 M(+29.3%) | -$8.53 M(+69.4%) |
| Sept 2012 | - | -$2.71 M(+134.2%) | -$5.04 M(+116.0%) |
| June 2012 | - | -$1.16 M(-0.3%) | -$2.33 M(+96.6%) |
| Mar 2012 | - | -$1.16 M(>+9900.0%) | -$1.19 M(+3839.9%) |
| Dec 2011 | - | -$8300.00(+59.6%) | -$30.10 K(+11.5%) |
| Sept 2011 | - | -$5200.00(-55.6%) | -$27.00 K(+2.3%) |
| June 2011 | -$26.50 K(+29.3%) | -$11.70 K(+138.8%) | -$26.40 K(+18.4%) |
| Mar 2011 | - | -$4900.00(-5.8%) | -$22.30 K(+0.5%) |
| Dec 2010 | - | -$5200.00(+13.0%) | -$22.20 K(+4.2%) |
| Sept 2010 | - | -$4600.00(-39.5%) | -$21.30 K(+27.5%) |
| June 2010 | - | -$7600.00(+58.3%) | -$16.70 K(+83.5%) |
| June 2010 | -$20.50 K | - | - |
| Mar 2010 | - | -$4800.00(+11.6%) | -$9100.00(+111.6%) |
| Dec 2009 | - | -$4300.00 | -$4300.00 |
FAQ
- What is ADMA Biologics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for ADMA Biologics?
- What is ADMA Biologics annual EBITDA year-on-year change?
- What is ADMA Biologics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for ADMA Biologics?
- What is ADMA Biologics quarterly EBITDA year-on-year change?
- What is ADMA Biologics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for ADMA Biologics?
- What is ADMA Biologics TTM EBITDA year-on-year change?
What is ADMA Biologics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ADMA is $5.12 M
What is the all time high annual EBITDA for ADMA Biologics?
ADMA Biologics all-time high annual earnings before interest, taxes, depreciation & amortization is $5.12 M
What is ADMA Biologics annual EBITDA year-on-year change?
Over the past year, ADMA annual earnings before interest, taxes, depreciation & amortization has changed by +$44.63 M (+112.96%)
What is ADMA Biologics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ADMA is $42.19 M
What is the all time high quarterly EBITDA for ADMA Biologics?
ADMA Biologics all-time high quarterly earnings before interest, taxes, depreciation & amortization is $42.19 M
What is ADMA Biologics quarterly EBITDA year-on-year change?
Over the past year, ADMA quarterly earnings before interest, taxes, depreciation & amortization has changed by +$31.13 M (+281.62%)
What is ADMA Biologics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ADMA is $98.83 M
What is the all time high TTM EBITDA for ADMA Biologics?
ADMA Biologics all-time high TTM earnings before interest, taxes, depreciation & amortization is $98.83 M
What is ADMA Biologics TTM EBITDA year-on-year change?
Over the past year, ADMA TTM earnings before interest, taxes, depreciation & amortization has changed by +$88.95 M (+900.18%)